Open Mic: Next in Health series - Multi-omics intelligence

Описание: Many thanks to everyone who joined us for our latest Open Mic session — a thought-provoking discussion on how multi-omics technologies are reshaping disease understanding and driving a new era of precision drug development.

Here are some of the key takeaways from the conversation on turning multi-layered biology into confident R&D decisions:

✔️ From data to decisions: Integrated multi-omics approaches are unlocking deeper biological insight, but translating complex datasets into actionable outcomes remains a major challenge for pharma R&D teams.
✔️ Platforms over point solutions: As the industry moves beyond single-omics tools, scalability, interoperability and end-to-end integration are becoming essential for real-world translational impact.
✔️ Separating value from hype: While some integrated omics platforms are already delivering measurable results, others are still proving their relevance — highlighting what it truly takes for startups and technology partners to earn trust within pharma.

The discussion offered a candid look at where multi-omics is delivering today, where expectations need recalibration and how these platforms can meaningfully shape the next generation of medicines.

🙏 A huge thank you to our expert panel for sharing their perspectives and experiences:

Ella Dehghani, Founder & Lead Organiser, Swiss Healthcare Roundtable, EllaVates
Elodie Pronier, VP Biomedical Discovery, Owkin
Abdullah Kahraman, Professor, Data Science in Life Sciences, FHNW
Christiaan Klijn, Global Head Oncology Data Science, Novartis

👉 Don’t miss the next Open Mic — sign up here to get your invitation: https://www.dayone.swiss/news-sign-up/

This event is organized by DayOne and hosted at the Switzerland Innovation Park Basel Area.
Many thanks to Novartis for sponsoring the inspiring venue and networking Apéro.